Geode Capital Management, LLC Capricor Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.39 Trillion
  • Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 963,080 shares of CAPR stock, worth $5.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
963,080
Previous 901,379 6.85%
Holding current value
$5.94 Million
Previous $8.55 Million 11.8%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$6.34 - $14.23 $391,184 - $878,005
61,701 Added 6.85%
963,080 $9.56 Million
Q1 2025

May 13, 2025
BUY
$9.49 - $16.11 $207,935 - $352,986
21,911 Added 2.49%
901,379 $8.55 Million
Q4 2024

Feb 12, 2025
BUY
$12.9 - $21.99 $3.11 Million - $5.31 Million
241,279 Added 37.81%
879,468 $12.2 Million
Q3 2024

Nov 12, 2024
SELL
$3.56 - $15.21 $12,047 - $51,470
-3,384 Reduced 0.53%
638,189 $9.71 Million
Q2 2024

Aug 09, 2024
BUY
$4.63 - $7.09 $1.45 Million - $2.22 Million
313,096 Added 95.32%
641,573 $3.06 Million
Q1 2024

May 13, 2024
BUY
$3.61 - $6.88 $44,327 - $84,479
12,279 Added 3.88%
328,477 $2.23 Million
Q4 2023

Feb 13, 2024
BUY
$2.71 - $5.08 $128,914 - $241,655
47,570 Added 17.71%
316,198 $1.55 Million
Q3 2023

Nov 13, 2023
SELL
$3.42 - $7.85 $101,553 - $233,097
-29,694 Reduced 9.95%
268,628 $918,000
Q2 2023

Aug 11, 2023
BUY
$3.76 - $5.05 $250,540 - $336,496
66,633 Added 28.76%
298,322 $1.43 Million
Q1 2023

May 15, 2023
BUY
$3.78 - $5.03 $21,088 - $28,062
5,579 Added 2.47%
231,689 $977,000
Q4 2022

Feb 13, 2023
BUY
$3.36 - $6.55 $13,698 - $26,704
4,077 Added 1.84%
226,110 $872,000
Q3 2022

Nov 14, 2022
BUY
$3.61 - $6.08 $57,651 - $97,097
15,970 Added 7.75%
222,033 $1.33 Million
Q2 2022

Aug 12, 2022
SELL
$2.89 - $4.51 $44,936 - $70,125
-15,549 Reduced 7.02%
206,063 $719,000
Q1 2022

May 13, 2022
BUY
$2.83 - $5.68 $45,393 - $91,107
16,040 Added 7.8%
221,612 $760,000
Q3 2021

Nov 12, 2021
BUY
$3.8 - $5.23 $78,211 - $107,643
20,582 Added 11.13%
205,572 $826,000
Q2 2021

Aug 13, 2021
BUY
$3.16 - $5.72 $42,897 - $77,649
13,575 Added 7.92%
184,990 $948,000
Q1 2021

May 12, 2021
BUY
$3.63 - $7.93 $179,935 - $393,082
49,569 Added 40.68%
171,415 $802,000
Q4 2020

Feb 12, 2021
BUY
$3.43 - $5.23 $21,718 - $33,116
6,332 Added 5.48%
121,846 $417,000
Q3 2020

Nov 13, 2020
BUY
$4.08 - $9.81 $343,246 - $825,305
84,129 Added 268.05%
115,514 $606,000
Q2 2020

Aug 13, 2020
BUY
$1.0 - $8.5 $18,340 - $155,890
18,340 Added 140.59%
31,385 $144,000
Q2 2019

Aug 14, 2019
BUY
$2.75 - $6.4 $35,873 - $83,488
13,045 New
13,045 $43,000

Others Institutions Holding CAPR

# of Institutions
141
Shares Held
12.4M
Call Options Held
4.99M
Put Options Held
5.52M
View Full List

About CAPRICOR THERAPEUTICS, INC.

CAPR Quotes by TradingView
  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $150M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email